Primidone
| Primidone | |
|---|---|
| Salts [] | |
|---|---|
| Sodium primidone | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 218.25 g/mol [1] |
| Appearance | Crystals [1] |
| Odor | Odorless [1] |
| Taste | Practically tasteless [1] |
| Melting point | 538 to 540 °F (NTP, 1992) [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1] |
| Solubility | less than 1 mg/mL at 66 °F (NTP, 1992) [1] |
| Predicted LogP | 0.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H14N2O2 |
| IUPAC name | 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione |
| SMILES | CCC1(C(=O)NCNC1=O)C2=CC=CC=C2 |
| InChI | InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16) |
| InChIKey | DQMZLTXERSFNPB-UHFFFAOYSA-N |
| CAS number | 125-33-7 |
| UNII | 13AFD7670Q |
| PubChem CID | 4909 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | Primidone: 5-18 h,, Phenobarbital: 75-120 h,, PEMA: 16 h, Time–reach steady state:, Primidone: 2-3 days,, Phenobarbital&PEMA 1-4weeks[3][4] |
| Metabolism | Liver |
| Excretion | Kidney |
| Routes of administration | By mouth |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - ip: 332 mg/kg - oral: 280 mg/kg Rat: - ip: 240 mg/kg - oral: 1500 mg/kg [1] |
Primidone (also known as Primaclone, Mysoline, Lepimidin, 2-Deoxyphenobarbital, Lepsiral, Liskantin, Milepsin, Mylepsin, Mysedon or Primakton) is a substance of the phenethylamine and barbiturate class.
Chemistry
Salts []
Primidone is typically found in the form of its sodium salt.
Stereochemistry []
Primidone is achiral.
Druglikeness
Lipinski's rule of five
Primidone matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- antiepileptics (N03)
- antiepileptics (N03A)
- barbiturates and derivatives (N03AA)
- (N03AA03)
- primidone (N03AA03)
MeSH Classification
Mechanism of action []
Primidone and its metabolites, phenobarbital and phenylethylmalonamide (PEMA), are active anticonvulsants. Primidone does not directly interact with GABA-A receptors or chloride channels but phenobarbital does. Primidone alters transmembrane sodium and calcium channel transport, reducing the frequency of nerve firing, which may be responsible for the primidone’s effect on convulsions and essential tremor. [1]
Medical side effects []
40 side effects listed on drug labels in SIDER 4.1 (primidone).
- Agranulocytosis
- Anaemia
- Anaemia megaloblastic
- Decreased appetite
- Arthralgia
- Musculoskeletal discomfort
- Ataxia
- Mental disorder
- Connective tissue disorder
- Muscle contracture
- Depression
- Diplopia
- Dizziness
- Somnolence
- Emotional disorder
- Dermatitis
- Rash
- Eruption
- Eye disorder
- Asthenia
- Fatigue
- Gastrointestinal disorder
- Headache
- Blood disorder
- Systemic lupus erythematosus
- Nausea
- Nervous system disorder
- Nystagmus
- Psychotic disorder
- Vertigo
- Vomiting
- Apathy
- Flat affect
- Malnutrition
- Skin disorder
- Personality change
- Aplasia
- Suicidal ideation
- Visual impairment
- Suicidal behaviour
Indications
- Bone disorder
- Epilepsy
- Jacksonian seizures
- Myoclonus
- Tonic-clonic seizures
Legal status []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4909, Primidone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4909
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Primidone. UNII: 13AFD7670Q. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/13AFD7670Q
Primidone (Mysoline). Pharmacology Guide for Brain Injury Treatment. 2003–2005. http://www.birf.info/home/bi-tools/qlinks_anticon.html
Therapeutic Drug Levels. YNHH Laboratory Manual - Reference Documents. 1998. http://info.med.yale.edu/labmed/clinical/labman/D011.html
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Primidone SERB 50mg Tablets - Summary of Product Characteristics (SmPC). (emc). 18 August 2014. https://www.medicines.org.uk/emc/product/2941/smpc
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:01:45 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 18:01:41 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:01:41 |
| gsrs | ok | 2026-11-20 18:01:42 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014932) | 2026-11-20 18:01:41 |
| kegg | ok | 2026-11-20 18:01:43 |
| pubchem | ok | 2026-11-20 18:01:41 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:01:41 | |
| sider | ok | 2026-11-20 18:01:41 |
| structure | ok | 2026-11-20 18:01:41 |
| wikipedia | ok | 2026-11-20 18:01:41 |